1-3 of 3
Marcella Fontana
Close
Sort by
Journal Articles

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

Rossana Maffei, Silvia Martinelli, Rita Santachiara, Davide Rossi, Carla Guarnotta, Elisa Sozzi, Antonella Zucchetto, Gian Matteo Rigolin, Stefania Fiorcari, Ilaria Castelli, Marcella Fontana, Valeria Coluccio, Giovanna Leonardi, Patrizia Zucchini, Claudio Tripodo, Antonio Cuneo, Valter Gattei, Giovanni Del Poeta, Francesco Forconi, Gianluca Gaidano, Giuseppe Torelli, Roberto Marasca
Journal: Blood
Blood (2010) 116 (4): 584–592.
https://doi.org/10.1182/blood-2009-11-252494
Published: 2010
Includes: Supplemental data
Journal Articles

Angiopoietin-2 Plasma Dosage Predicts Time to First Treatment (TTFT) and Overall Survival (OS) in Chronic Lymphocytic Leukemia.

Rossana Maffei, Silvia Martinelli, Rita Santachiara, Davide Rossi, Gian Matteo Rigolin, Stefania Fiorcari, Marcella Fontana, Valeria Coluccio, Giovanna Leonardi, Patrizia Zucchini, Antonio Cuneo, Valter Gattei, MD, Giovanni Del Poeta, Francesco Forconi, Gianluca Gaidano, Giuseppe Torelli, Roberto Marasca
Journal: Blood
Blood (2009) 114 (22): 1260.
https://doi.org/10.1182/blood.V114.22.1260.1260
Published: 2009
Journal Articles

Angiopoietin-2 Expression in B-Cell Chronic Lymphocytic Leukemia: Association with Clinical Outcome and Immunoglobulin Heavy-Chain Mutational Status.

Rossana Maffei, Silvia Martinelli, Ilaria Castelli, Rita Santachiara, Elena Morandi, Patrizia Zucchini, Marcella Fontana, Anna Maria Colacci, Roberto Serra, Roberto Marasca, Giuseppe Torelli
Journal: Blood
Blood (2006) 108 (11): 2780.
https://doi.org/10.1182/blood.V108.11.2780.2780
Published: 2006